West Pharmaceutical Services (NYSE: WST) is set to announce its financial results for the third quarter of 2024 on Thursday 24th October 2024. This highly anticipated announcement is scheduled to take place before market open. Investors will have the opportunity to learn more about the company's performance during the quarter.
In accordance with the forecasts of financial specialists on Wall Street, the firm is primed to announce an anticipated $1.50 profit per share for the quarter. Additionally, the company is projected to reveal a total revenue of $709.29 million for this particular period.
Looking back at the corresponding quarter from the previous year, the company's earnings report revealed a per-share income of $2.16. This notable figure was attributed to the company's total revenue, which settled at an impressive $747.4 million during that specific quarter.
Wall street experts have shared their forecasts for the company's annual performance, indicating that they predict the company will achieve a total revenue of $2.87 billion. Additionally, they are expecting the earnings per share for the company to hit profit of $6.51 during the fiscal year.
| Period | EPS Actual |
EPS Growth* |
Revenue Actual |
Revenue Growth* |
|---|---|---|---|---|
| Historical Earnings Insight | ||||
| Q2 2024 | $1.52 | -28.0% | 702.10 M | -6.9% |
| Q1 2024 | $1.56 | -21.2% | 695.40 M | -3.0% |
| Q4 2023 | $1.83 | +3.4% | 732.00 M | +3.3% |
| Q3 2023 | $2.16 | +6.4% | 747.40 M | +8.8% |
| Q2 2023 | $2.11 | -14.6% | 753.80 M | -2.3% |
| *Growth on year-over-year basis | ||||
The business has scheduled a conference call on 24th October 2024 at 09:00 AM eastern time to discuss Q3 financial results.
During Tuesday's trading, West Pharmaceutical Services (WST) shares reached a low of $282.60 and a high of $287.05, along with a total volume of 588.90 thousand shares. The stock ended the regular trading session at $286.40, demonstrating decline of 0.3 percent.
